Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.

Slides:

Advertisements

Similar presentations

1 European Clinical Research in a Global Setting FEAM Launch Event 25 January 2011 European Medical Research Councils Dr Stephane Berghmans.

Advertisements

Clinical Trials on Trial The Patient Perspective Wim Vandevelde European AIDS Treatment Group (EATG) HAI Europe Open Seminar - November 21st Berlin.

Background information

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.

Vitality Institute Commission Forum Commission Recommendations The Vitality Institute's mission is to advance knowledge about the evolving science and.

Your Tax Dollars at Work: Community Participation in DAIDS Funded HIV Clinical Trials Claire Rappoport, Dwight Peavy, Hamilton Richardson and Rona Siskind.

THE AFRICA LOCAL GOVERNMENT ACTION FORUM (ALGAF) PHASE IV SESSION V

European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.

Vitality Institute Commission Forum Business for Health: Fostering Healthy Workplaces The Vitality Institute's mission is to advance knowledge about the.

NICE and NICE’s equality programme in 2012 Nick Doyle Clinical and public health analyst.

Community engagement in biomedical research, new perspectives of collaboration with HIV prevention research Jean-Marie Le Gall AIDES & Coalition Plus IAS.

World Health Organization Conference on Developing New SPHs Jerusalem March, 2002 What should an MPH graduate be able to do at the end of the training.

1 A frank dialogue on the future of HIV treatment All the way from the factory to the patient Sunday 20 th July 2014, 13:30 – 15:30 Presented at the 20.

A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE EPF Annual General Meeting 19 May 2010 EPF Annual General Meeting 19 May 2010.

CITAM+ Engaging HIV Civil Society in TB ACSM Meeting, Cancun 30 Nov 2009 Carol Nawina Nyirenda National Coordinator Community Initiative for TB, HIV/AIDS.

Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.

1 The European Paediatric Initiative Agnès Saint Raymond, MD Scientific Advice and Orphan Drugs The European Medicines Evaluation Agency.

The Value of Partnerships in Fighting HIV/AIDS in Romania: Bringing Children New Hope Jeffrey L. Sturchio Vice President, External Affairs Europe, Middle.

Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.

THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.

Community Representation Structure. Site Coordinating Centers (SCC) Community Advisory Boards (CABs) Leadership Level Cross-Network Level Network Level.

Jacques Normand, Ph.D. Director, AIDS Research Program National Institute on Drug Abuse NIDA’s New HIV/AIDS Research Program.

Working with UICC’s 800+ member organisations in 155 countries, the McCabe Centre aims to build legal capacity globally. Based at CCV in Melbourne, Australia.

BREAST HEALTH GLOBAL INITIATIVE(BHGI) SUPPORTIVE CARE GUIDELINES& THEIR ROLE IN ADVOCACY : The Uganda Experience Gertrude Nakigudde Patient Advocate Uganda.

Better Science with Sex and gender in mind Shifting the paradigm in HIV research XIX IAC Washington DC 23 July :30 – 20:30 Dr. Shirin Heidari, IAS-ILF.

Fogarty International Center: HIV Research Training Program: New Applications and Strategies Gene D. Morse, PharmD University at Buffalo AIDS International.

Presentation by Lia van Ginneken – EMP Secretary & João Salazar – EMP Chairman 21st February 2009.

Downloaded from

WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.

DoHDST. South African AIDS Vaccine Initiative (SAAVI)  Established in late1999 by the South African government.  Based at the Medical Research Council.

Washington D.C., USA, July 2012www.aids2012.org The HIV/AIDS Civil Society Forum and Think Tank: from policy to action Anna Zakowicz HIV/AIDS Civil.

EPHA Presentation EPHA, the EU and Health. EPHA Presentation European Public Health Alliance A network of more that 100 non governmental and not-for-profit.

Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.

Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.

HIV i-Base: Community outreach MRC April 2006 Community outreach in MRC national and international trials Simon Collins HIV i-Base, London UK-CAB and ECAB.

Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.

A presentation of The Association of the Pharmaceutical Industry in Norway (LMI)

Use of Pharmacoeconomics & Outcomes Research Information in Health Care Decisions – SURVEY Results Peter K Wong, PhD, MS, MBA, RPh Steve Marx, PharmD,

Volservnet Voluntary Services and Networking A project in collaboration with the Ministry of Health, the Elderly and Community Care.

Training course on the Pharmacovigilance of antiretroviral medicines 23 – 28 November 2009 Rationale, Objectives and Expected Outcomes.

Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 23th, 2014 TasP – Leadership.

HANC and Community Partners Overview November 20, 2007 Michael Petillo, Project Coordinator.

It began here: Nothing about us without us

Translation of research data into programmes and practice: UN Work Plan on Male Circumcision Translation of research data into programmes and practice:

Hankins UNAIDS Mexico Aug 6/08 Women and clinical trials: Where have we been and where are we going? ‘Women and clinical trials: where have we been and.

Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.

The Role of PLWHA in Universal Access to Care and Treatment by 2010 Presented by Christopher Dorsett Chair, CRN+

Focusing on Zonta’s Mission Focusing on Zonta’s Mission At the international level Zonta supports educational scholarships, violence prevention programs.

Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.

1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.

TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.

 Drug Pricing and the Impact on Treatment Access - International Wim Vandevelde - European AIDS Treatment Group (EATG) 2010 HIV Research Catalyst Forum.

Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.

Adult AIDS Clinical Trials Group International Therapeutic Initiative.

Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.

HEALTH ECONOMIST FOR THE WORLD HEALTH ORGANIZATION Health economist for the World Health Organization. Name Date.

Patient Engagement throughout the Biopharmaceutical Lifecycle: Tips for Effective Patient Advocate/Industry Collaboration to Improve Patient Access and.

M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.

Slide 1 The contribution of a world-class regulatory environment to the future of the industry in Ireland Pat O’Mahony Chief Executive, Irish Medicines.

 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.

European Patients’ Academy on Therapeutic Innovation – The project is receiving support from the.

Third EU Health Programme National Info day Athens, 21 April 2016 Courtesy of Irène Athanassoudis DG SANTE.

Dr. Sophia Kisting Director, ILO Programme on HIV and AIDS and the world of work Joint ILO and WHO guidelines on Health Services and HIV/AIDS.

Richard Murrugarra – Centurion

A capacity building programme for patient representatives

20:20 Vision Making new and old money work better

Community Participation in Research

Participation of Patient Advocates in Community Advisory Boards A case-study: the HIV European Community Advisory Board (ECAB)

Global Alliance for Patient Access (GAfPA) Miami, 26 May 2018

Every Mother, Every Child: Closing the Gaps in HIV Management

Presentation transcript:

Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne

"Learning more than from anyone else in this journey" Michel Sidibe, Sunday 20 July 2014

Informed Patient/Advocate Treatment information & Co decision about personal health From scrutiny of public money on research, to grants review (NIH, ACTG, DG Research, Martin Delaney Collaboratory) Monitoring and participation in Drug development and clinical research (Private, ACTG, NEAT) Members of Scientific Committees, CABs and Guideline Panels Experts and members at Regulatory Authorities (FDA-EMA) Heads of major research focused organisations (AMFAR – Forum for Collaborative Research) International Organisations (WHO, UNAIDS, Global Fund, UNITAID, Medicines Patent Pool)

EU–Russia Dialogue on HIV/AIDS December 2007, Moscow

Denver Declaration (1983) “Nothing about Us, Without Us” We condemn attempts to label us as “victims”, which implies defeat, and we are only occasionally “patients”, which implies passivity, helplessness and dependence upon the care of others. We are “people with AIDS”

Denver Declaration (1983) “Nothing about Us, Without Us” We recommend that people with AIDS: 2 Be involved at every level of AIDS decision- making and specifically 3 Be included in all AIDS forums with equal credibility as other participants, to share their own experiences and knowledge

The 80s….

EU–Russia Dialogue on HIV/AIDS December 2007, Moscow

Impact of ARVs

Dallas Buyers Club a film by Jean-Marc Valle

Community mobilisation

How to Survive a Plague a film by David France

ACT UP

A History of ACT UP a film by Jim Hubbard

1988 FDA demo

1990 NIH demo

CABs – Community Advisory Boards Adult AIDS Clinical Trials Group (AACTG) Community Programs for Clinical Research on AIDS (CPCRA) Pediatric AIDS Clinical Trials Group (PACTG) HIV Prevention Trials Network (HPTN) HIV Vaccine Trials Network (HVTN) Medical Research Council (MRC) Agence Nationale de Recherche sur le Sida (ANRS) Numerous industry led – (drug or trial specific)

EATG (European AIDS Treatment Group) Founded in members from 40 countries involved in 80 NGOs and related to 36 networks Mission Ensure fastest possible access to state of the art medical products or devices and diagnostic tests that can contribute to the prevention or treatment of HIV and related diseases Fields of activities Treatment information Training and capacity building Drug development and clinical research Policy / Advocacy

to advise the research community on the needs of the local community and the appropriateness of proposed research to advise the local community on the aims and expectations of a research proposal and the appropriateness of the research ECAB – November 1997 (European Community Advisory Board)

Trainings & Lectures Good Clinical Practice Statistics Immunology Pharmacology Virology Hepatitis co-infection Pharmacovigilance Reproductive health Clinical Trial’s design Evidence based medicine Clinical Trials Networks Cohorts EMEA – Regulatory authorities Pharmacoeconomics - Health Economics Prevention Research Media Relations

2004

2007 (updated 2011)

2010

2012

2014

The Last Frontier

New Paradigm for Science Drug & Clinical Research Social Sciences Implementation Science Cure research Epidemiology & Disease burden Evidence based Policy

Aknowledgments Carlton Hogan† Lynda Dee Matt Sharp Kevin Fisher Brian West